ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	7/50	120/7206	1.64466967665e-05
ko04931	Insulin resistance	7/50	137/7206	3.8884060575e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	7/50	191/7206	0.000313194811853
ko04620	Toll-like receptor signaling pathway	5/50	100/7206	0.000601290039429
ko05160	Hepatitis C	6/50	153/7206	0.000610304578564
ko04621	NOD-like receptor signaling pathway	6/50	157/7206	0.000699493896533
ko05164	Influenza A	6/50	167/7206	0.00096698892872
ko05161	Hepatitis B	6/50	173/7206	0.00116171700922
ko05168	Herpes simplex infection	6/50	182/7206	0.00150880642665
ko04932	Non-alcoholic fatty liver disease (NAFLD)	6/50	182/7206	0.00150880642665
ko04211	Longevity regulating pathway	5/50	123/7206	0.00153123890963
ko05142	Chagas disease (American trypanosomiasis)	5/50	130/7206	0.00195611855029
ko04630	Jak-STAT signaling pathway	5/50	132/7206	0.00209197708233
ko04380	Osteoclast differentiation	5/50	134/7206	0.00223462694208
ko05166	HTLV-I infection	7/50	292/7206	0.00373101797553
ko04064	NF-kappa B signaling pathway	4/50	96/7206	0.00426401138852
ko04722	Neurotrophin signaling pathway	5/50	160/7206	0.00479842884544
ko04725	Cholinergic synapse	5/50	160/7206	0.00479842884544
ko04068	FoxO signaling pathway	5/50	167/7206	0.0057476757287
ko05215	Prostate cancer	4/50	111/7206	0.00712507718638
ko04210	Apoptosis	5/50	180/7206	0.00785159830448
ko05152	Tuberculosis	5/50	187/7206	0.00918325570927
ko05221	Acute myeloid leukemia	3/50	63/7206	0.00932052699255
ko05162	Measles	4/50	120/7206	0.00933811020066
ko04060	Cytokine-cytokine receptor interaction	5/50	191/7206	0.0100107763331
ko05145	Toxoplasmosis	4/50	126/7206	0.0110385100449
ko04922	Glucagon signaling pathway	4/50	128/7206	0.0116469785486
ko04933	AGE-RAGE signaling pathway in diabetic complications	4/50	135/7206	0.0139459787423
ko04115	p53 signaling pathway	3/50	74/7206	0.0144273370542
ko01524	Platinum drug resistance	3/50	76/7206	0.0154958872278
ko05214	Glioma	3/50	79/7206	0.0171807664194
ko03040	Spliceosome	4/50	145/7206	0.0177035964618
ko05230	Central carbon metabolism in cancer	3/50	81/7206	0.0183589756155
ko05131	Shigellosis	3/50	82/7206	0.0189646201259
ko05220	Chronic myeloid leukemia	3/50	85/7206	0.0208478720647
ko04213	Longevity regulating pathway - multiple species	3/50	86/7206	0.0214977618336
ko05210	Colorectal cancer	3/50	86/7206	0.0214977618336
ko04917	Prolactin signaling pathway	3/50	87/7206	0.0221587330229
ko04662	B cell receptor signaling pathway	3/50	88/7206	0.0228307900334
ko05323	Rheumatoid arthritis	3/50	89/7206	0.0235139354991
ko04920	Adipocytokine signaling pathway	3/50	89/7206	0.0235139354991
ko05222	Small cell lung cancer	3/50	89/7206	0.0235139354991
ko04152	AMPK signaling pathway	4/50	161/7206	0.024932818175
ko04071	Sphingolipid signaling pathway	4/50	162/7206	0.0254359968323
ko05120	Epithelial cell signaling in Helicobacter pylori infection	3/50	92/7206	0.0256299031156
ko04650	Natural killer cell mediated cytotoxicity	3/50	97/7206	0.0293780406708
ko05146	Amoebiasis	3/50	99/7206	0.0309546318033
ko04960	Aldosterone-regulated sodium reabsorption	2/50	41/7206	0.0325771465137
ko04973	Carbohydrate digestion and absorption	2/50	42/7206	0.0340568348002
ko04217	Necroptosis	4/50	178/7206	0.0343316197494
ko01521	EGFR tyrosine kinase inhibitor resistance	3/50	106/7206	0.0368185381252
ko04150	mTOR signaling pathway	4/50	184/7206	0.0380827077224
ko04012	ErbB signaling pathway	3/50	109/7206	0.0394950849456
ko04215	Apoptosis - multiple species	2/50	47/7206	0.04183604268
ko05203	Viral carcinogenesis	5/50	277/7206	0.0419275607837
ko04070	Phosphatidylinositol signaling system	3/50	112/7206	0.042268704692
ko04024	cAMP signaling pathway	5/50	279/7206	0.0430309691235
ko04072	Phospholipase D signaling pathway	4/50	197/7206	0.0469955958955
ko04062	Chemokine signaling pathway	4/50	201/7206	0.0499546108772